|Bid||0.00 x 301500|
|Ask||0.00 x 38800|
|Day's range||9.48 - 9.50|
|52-week range||3.45 - 9.50|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||04 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||12.10|
The big shareholder groups in Kadmon Holdings, Inc. (NASDAQ:KDMN) have power over the company. Generally speaking, as a company grows, institutions...
Kadmon Holdings, Inc. (KDMN) delivered earnings and revenue surprises of 0.00% and 3393.11%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
NEW YORK, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Acceleron Pharma Inc. (NASDAQ: XLRN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Merck & Co., Inc. for $180.00 per share in cash. If you are an Acceleron shareholder, click here to learn more about your rights and options. ADTRAN, Inc. (NASDAQ: ADTN) concerning potenti